Table 4.
Network estimates and SUCRA ranking of the safety of antifungal agents used for the treatment of OPC among HIV-infected adults.
| Intervention | All RCTs | ||
|---|---|---|---|
| RR [95% CI] | p-Value | SUCRA Rank | |
| Nystatin | 0.33 (0.03,3.10) | 0.33 | 1 |
| Gentian violet | 0.38 (0.04,3.94) | 0.42 | 2 |
| Itraconazole | 0.89 (0.71,1.12) | 0.30 | 3 |
| Posaconazole | 0.94 (0.81,1.09) | 0.43 | 4 |
| Fluconazole | Reference | 5 | |
| Clotrimazole | 1.07 (0.72,1.61) | 0.22 | 6 |
| Miconazole | 1.12 (0.73,1.73) | 0.59 | 7 |
| Ketoconazole | 1.29 (0.76,2.20) | 0.34 | 8 |
| Overall inconsistency Chi-square (p value) | 1.57 (0.2106) | ||
| Number of studies | 12 | ||